Skyhawk Therapeutics has dosed the first subject in the randomised Phase II/III FALCON-HD trial of the oral small-molecule ...

The Huntington disease Digital Motor Score, derived from smartphone sensor-based motor tests, can improve detection of disease progression.

Huntington’s disease is a rare genetic disorder affecting movement, memory, and mood. Here’s what we know—and what’s ahead.

A new study reveals that transplanting healthy human glial progenitor cells into adult mice with Huntington’s disease can delay motor and cognitive decline and extend lifespan.

Highlights: NUZ-001 and its active metabolite NUZ-001 Sulfone demonstrated significant neuroprotective effects in a zebrafish ...

A five-minute smartphone test using balance and tapping can accurately detect early motor symptoms of Huntington’s disease, providing a faster, more accessible way to track progression and support ...

Analysts reacted positively to the news that uniQure is in alignment with the FDA on an accelerated approval pathway and on ...

AMT-130 has been granted the FDA’s Regenerative Medicine Advance Therapy (RMAT) designation and Breakthrough Therapy designation, the first therapy for Huntington’s disease to receive an RMAT ...

These results are meaningful because they show how INGREZZA alleviates chorea symptoms and therefore helps people with Huntington's disease in their everyday lives." In the 12-week, Phase 3 KINECT ...

Huntington’s disease symptoms are linked to expanding ... and cognitive issues and uncontrollably jerking motions known as chorea, even though the majority of people inherit variants of HTT ...

Robust and sustained improvements in chorea associated with Huntington's disease were observed through Week 104 in patients, irrespective of concomitant antipsychotic therapy use. These results ...